These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33045869)

  • 21. Chemokine-induced recruitment of genetically modified bone marrow cells into the CNS of GM1-gangliosidosis mice corrects neuronal pathology.
    Sano R; Tessitore A; Ingrassia A; d'Azzo A
    Blood; 2005 Oct; 106(7):2259-68. PubMed ID: 15941905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [GM1-gangliosidosis knockout mouse].
    Oshima A
    No To Hattatsu; 1998 Mar; 30(2):148-51. PubMed ID: 9545780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generalized CNS disease and massive GM1-ganglioside accumulation in mice defective in lysosomal acid beta-galactosidase.
    Hahn CN; del Pilar Martin M; Schröder M; Vanier MT; Hara Y; Suzuki K; Suzuki K; d'Azzo A
    Hum Mol Genet; 1997 Feb; 6(2):205-11. PubMed ID: 9063740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AAVrh10 vector corrects pathology in animal models of GM1 gangliosidosis and achieves widespread distribution in the CNS of nonhuman primates.
    Hocquemiller M; Giersch L; Mei X; Gross AL; Randle AN; Gray-Edwards HL; Hudson JA; Todeasa S; Stoica L; Martin DR; Sena-Esteves M; Aiach K; Laufer R
    Mol Ther Methods Clin Dev; 2022 Dec; 27():281-292. PubMed ID: 36320411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GM1-ganglioside-mediated activation of the unfolded protein response causes neuronal death in a neurodegenerative gangliosidosis.
    Tessitore A; del P Martin M; Sano R; Ma Y; Mann L; Ingrassia A; Laywell ED; Steindler DA; Hendershot LM; d'Azzo A
    Mol Cell; 2004 Sep; 15(5):753-66. PubMed ID: 15350219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A bicyclic 1-deoxygalactonojirimycin derivative as a novel pharmacological chaperone for GM1 gangliosidosis.
    Takai T; Higaki K; Aguilar-Moncayo M; Mena-Barragán T; Hirano Y; Yura K; Yu L; Ninomiya H; García-Moreno MI; Sakakibara Y; Ohno K; Nanba E; Ortiz Mellet C; García Fernández JM; Suzuki Y
    Mol Ther; 2013 Mar; 21(3):526-32. PubMed ID: 23337983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic challenge for the rare lysosomal storage disease: Late infantile GM1 gangliosidosis.
    Lee JS; Choi JM; Lee M; Kim SY; Lee S; Lim BC; Cheon JE; Kim IO; Kim KJ; Choi M; Seong MW; Chae JH
    Brain Dev; 2018 May; 40(5):383-390. PubMed ID: 29439846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebrospinal fluid biomarkers showing neurodegeneration in dogs with GM1 gangliosidosis: possible use for assessment of a therapeutic regimen.
    Satoh H; Yamato O; Asano T; Yonemura M; Yamauchi T; Hasegawa D; Orima H; Arai T; Yamasaki M; Maede Y
    Brain Res; 2007 Feb; 1133(1):200-8. PubMed ID: 17196562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human
    Latour YL; Yoon R; Thomas SE; Grant C; Li C; Sena-Esteves M; Allende ML; Proia RL; Tifft CJ
    Mol Genet Metab Rep; 2019 Dec; 21():100513. PubMed ID: 31534909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myelin abnormalities in the optic and sciatic nerves in mice with GM1-gangliosidosis.
    Heinecke KA; Luoma A; d'Azzo A; Kirschner DA; Seyfried TN
    ASN Neuro; 2015; 7(1):. PubMed ID: 25694553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correction of acid beta-galactosidase deficiency in GM1 gangliosidosis human fibroblasts by retrovirus vector-mediated gene transfer: higher efficiency of release and cross-correction by the murine enzyme.
    Sena-Esteves M; Camp SM; Alroy J; Breakefield XO; Kaye EM
    Hum Gene Ther; 2000 Mar; 11(5):715-27. PubMed ID: 10757351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intermittent enzyme replacement therapy with recombinant human β-galactosidase prevents neuraminidase 1 deficiency.
    Luu AR; Wong C; Agrawal V; Wise N; Handyside B; Lo MJ; Pacheco G; Felix JB; Giaramita A; d'Azzo A; Vincelette J; Bullens S; Bunting S; Christianson TM; Hague CM; LeBowitz JH; Yogalingam G
    J Biol Chem; 2020 Sep; 295(39):13556-13569. PubMed ID: 32727849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An autopsy case of G
    Uchino A; Nagai M; Kanazawa N; Ichinoe M; Yanagisawa N; Adachi K; Nanba E; Ishiura H; Mitsui J; Tsuji S; Suzuki K; Murayama S; Nishiyama K
    Neuropathology; 2020 Aug; 40(4):379-388. PubMed ID: 32219895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attenuation of ganglioside GM1 accumulation in the brain of GM1 gangliosidosis mice by neonatal intravenous gene transfer.
    Takaura N; Yagi T; Maeda M; Nanba E; Oshima A; Suzuki Y; Yamano T; Tanaka A
    Gene Ther; 2003 Aug; 10(17):1487-93. PubMed ID: 12900764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pharmacological chaperone N-n-butyl-deoxygalactonojirimycin enhances β-galactosidase processing and activity in fibroblasts of a patient with infantile GM1-gangliosidosis.
    Mohamed FE; Al Sorkhy M; Ghattas MA; Al-Gazali L; Al-Dirbashi O; Al-Jasmi F; Ali BR
    Hum Genet; 2020 May; 139(5):657-673. PubMed ID: 32219518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glb1 knockout mouse model shares natural history with type II GM1 gangliosidosis patients.
    Nicoli ER; Huebecker M; Han ST; Garcia K; Munasinghe J; Lizak M; Latour Y; Yoon R; Glase B; Tyrlik M; Peiravi M; Springer D; Baker EH; Priestman D; Sidhu R; Kell P; Jiang X; Kolstad J; Kuhn AL; Shazeeb MS; Acosta MT; Proia RL; Platt FM; Tifft CJ
    Mol Genet Metab; 2023 Feb; 138(2):107508. PubMed ID: 36709532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inheritance of lysosomal acid beta-galactosidase activity and gangliosides in crosses of DBA/2J and knockout mice.
    Hauser EC; Kasperzyk JL; d'Azzo A; Seyfried TN
    Biochem Genet; 2004 Aug; 42(7-8):241-57. PubMed ID: 15487588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MRI/MRS as a surrogate marker for clinical progression in GM1 gangliosidosis.
    Regier DS; Kwon HJ; Johnston J; Golas G; Yang S; Wiggs E; Latour Y; Thomas S; Portner C; Adams D; Vezina G; Baker EH; Tifft CJ
    Am J Med Genet A; 2016 Mar; 170(3):634-44. PubMed ID: 26646981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel human model of the neurodegenerative disease GM1 gangliosidosis using induced pluripotent stem cells demonstrates inflammasome activation.
    Son MY; Kwak JE; Seol B; Lee DY; Jeon H; Cho YS
    J Pathol; 2015 Sep; 237(1):98-110. PubMed ID: 25925601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lysosomal accumulation of Trk protein in brain of GM₁ -gangliosidosis mouse and its restoration by chemical chaperone.
    Takamura A; Higaki K; Ninomiya H; Takai T; Matsuda J; Iida M; Ohno K; Suzuki Y; Nanba E
    J Neurochem; 2011 Aug; 118(3):399-406. PubMed ID: 21574998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.